Address
Email address
Phone number
Website
https://www.jmolner.comThe J. Molner Company | Get Chemistry Done! | Analytical ChemsitryAmplify your generic drug pipeline with the J. Molner Company | Contract injectable development for the US, Canada, and Europe | Analytical Chemistry Services | Commerical and R&D stability services with our Nordic Stability Service team.
Name
The J. Molner Company OÜ
Registry code
16049586
VAT number
EE102328305
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.09.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72111 - Research and experimental development on biotechnology
999 667 €
-190 699 €
-19%
2 396 €
(estimate is approximate)
678 950 €
26
Submitted
No tax arrears
-28%
-5%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| J.Molner AS 16579077 | 100% - 2 500.00 EUR | - | - | |
| Jason Michael Atticus Grenfell-Gardner 09.10.1974 (50) | - | Board member | Direct ownership | Founder |
| 2021 02.09.2022 | 2022 25.04.2023 | 2023 27.06.2024 | |
|---|---|---|---|
| Total Revenue | 505 260 € | 191 657 € | 999 667 € |
| Net profit (loss) for the period | -327 753 € | -620 098 € | -190 699 € |
| Profit Margin | -65% | -324% | -19% |
| Current Assets | 317 954 € | 260 903 € | 1 263 970 € |
| Fixed Assets | 107 843 € | 1 027 699 € | 2 801 854 € |
| Total Assets | 425 797 € | 1 288 602 € | 4 065 824 € |
| Current Liabilities | 392 946 € | 461 775 € | 931 873 € |
| Non Current Liabilities | 358 104 € | 1 022 178 € | 2 455 001 € |
| Total Liabilities | 751 050 € | 1 483 953 € | 3 386 874 € |
| Share Capital | - | - | - |
| Equity | -325 253 € | -195 351 € | 678 950 € |
| Employees | 13 | 19 | 26 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 679 495.86 € | 107 047.12 € | 113 881.44 € | 27 |
| 2023 Q4 | 806 800.97 € | 97 680.72 € | 104 092.89 € | 26 |
| 2023 Q3 | 339 109.44 € | 101 161.79 € | 107 297.84 € | 24 |
| 2023 Q2 | 293 984.73 € | 87 457.62 € | 93 245.64 € | 24 |
| 2023 Q1 | 126 878.87 € | 75 350.91 € | 78 818.48 € | 20 |
| 2022 Q4 | 143 007.3 € | 59 690.72 € | 62 757.12 € | 19 |
| 2022 Q3 | 464 236.7 € | 54 655.81 € | 58 203.69 € | 17 |
| 2022 Q2 | 59 291.42 € | 49 255.19 € | 52 396.15 € | 18 |
| 2022 Q1 | 171 487.53 € | 45 663.49 € | 48 654.24 € | 18 |
| 2021 Q4 | 64 026.23 € | 44 413.19 € | 47 182.6 € | 18 |
| 2021 Q3 | 100 018.86 € | 35 310.99 € | 37 937 € | 17 |
| 2021 Q2 | 71 818.29 € | 56 216.02 € | 60 467.87 € | 16 |
| 2021 Q1 | 35 456.38 € | 35 617.16 € | 38 533.14 € | 14 |
| 2020 Q4 | - | 3 408.14 € | 3 664.4 € | 10 |
